Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma

Clinical trial NCT06464861 · RECRUITING

Trial details

NCT number: NCT06464861
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Mediastinal B-cell Lymphoma (PMBCL)Mantle Cell Lymphoma (MCL)Diffuse Large B Cell Lymphoma( DLBCL)

Start date: 2024-06-20
Primary completion: 2026-06-30
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.